AM

Oceanview Holdings Announces Credit Rating Upgrades From AM Best

Retrieved on: 
Tuesday, November 7, 2023
Professional Services, Insurance, Finance, ICR, AM Best, Credit, Organization, AM, FSR, Asset–liability mismatch, Bermuda, Management

Oceanview Holdings, Ltd., a Bermuda company and ultimate parent of each of Oceanview Life and Annuity Company (“Oceanview Life”), an Alabama insurance company, and Oceanview Reinsurance Ltd., a Bermuda Class E insurance company (together “Oceanview”), today announced that global credit rating agency AM Best has upgraded the Financial Strength Rating (FSR) and Long-Term Issuer Credit Ratings (Long-Term ICR) of Oceanview.

Key Points: 
  • Oceanview Holdings, Ltd., a Bermuda company and ultimate parent of each of Oceanview Life and Annuity Company (“Oceanview Life”), an Alabama insurance company, and Oceanview Reinsurance Ltd., a Bermuda Class E insurance company (together “Oceanview”), today announced that global credit rating agency AM Best has upgraded the Financial Strength Rating (FSR) and Long-Term Issuer Credit Ratings (Long-Term ICR) of Oceanview.
  • AM Best upgraded Oceanview’s FSR to “A”(Excellent) and its Long-Term ICR to “a” (Excellent) from “a-“, assessing Oceanview’s balance sheet as “very strong” and the outlook of these ratings was revised to stable from positive.
  • “We are proud to have achieved this ratings upgrade from AM Best, which is indicative of our robust financial position, continued execution and results,” said William Egan, Chairman and Chief Executive Officer of Oceanview Holdings and Oceanview Life.
  • Andrew Kanelos, Executive Chairman & Chief Governance Officer of Oceanview Re, added “This upgrade reflects the Oceanview team’s commitment to providing high-quality services and its disciplined approach to governance and asset/liability management, all of which are fundamental to the strength and stability of our organizations and worthy of strong investment-grade credit ratings.”
    Additional details regarding these credit ratings are available at AM Best’s Recent Rating Activity web page.

BIRKENSTOCK APPOINTS NEW MANAGING DIRECTOR FOR GREATER CHINA: TIFFANY WU TO LEAD AND TO ACCELERATE THE COMPANY'S EXPANSION IN THE GROWTH REGION WITH THE LARGEST UNTAPPED WHITE SPACE POTENTIAL

Retrieved on: 
Tuesday, November 7, 2023
Ogilvy, Risk, Peking University, Security (finance), LINZ, AM, Environment, Growth, Prospectus, Marketing, University, University of California, Irvine, APMA, ARC, Greater, Fung, COVID-19, Appetite, PR, Retail, Greater China

LINZ AM RHEIN, Germany and SHANGHAI, Nov. 7, 2023 /PRNewswire/ -- BIRKENSTOCK has appointed Tiffany Wu as Managing Director Greater China, effective November 1, 2023. In this newly created position, Wu will lead the Greater China business area, which includes mainland China, Hong Kong and Taiwan, driving brand equity and sales in the region. She reports to Klaus Baumann, Chief Sales Officer of the BIRKENSTOCK Group.

Key Points: 
  • LINZ AM RHEIN, Germany and SHANGHAI, Nov. 7, 2023 /PRNewswire/ -- BIRKENSTOCK has appointed Tiffany Wu as Managing Director Greater China, effective November 1, 2023.
  • In this newly created position, Wu will lead the Greater China business area, which includes mainland China, Hong Kong and Taiwan, driving brand equity and sales in the region.
  • Oliver Reichert, Director of Birkenstock Holding plc and Chief Executive Officer of the BIRKENSTOCK Group: "Greater China is the strongest growth driver for us in the APMA region alongside India and Japan.
  • And in view of the latest economic outlook, we expect this positive trend to continue or accelerate.

BIRKENSTOCK APPOINTS NEW MANAGING DIRECTOR FOR GREATER CHINA: TIFFANY WU TO LEAD AND TO ACCELERATE THE COMPANY'S EXPANSION IN THE GROWTH REGION WITH THE LARGEST UNTAPPED WHITE SPACE POTENTIAL

Retrieved on: 
Tuesday, November 7, 2023
Ogilvy, Risk, Peking University, Security (finance), LINZ, AM, Environment, Growth, Prospectus, Marketing, University, University of California, Irvine, APMA, ARC, Greater, Fung, COVID-19, Appetite, PR, Retail, Greater China

LINZ AM RHEIN, Germany and SHANGHAI, Nov. 7, 2023 /PRNewswire/ -- BIRKENSTOCK has appointed Tiffany Wu as Managing Director Greater China, effective November 1, 2023. In this newly created position, Wu will lead the Greater China business area, which includes mainland China, Hong Kong and Taiwan, driving brand equity and sales in the region. She reports to Klaus Baumann, Chief Sales Officer of the BIRKENSTOCK Group.

Key Points: 
  • LINZ AM RHEIN, Germany and SHANGHAI, Nov. 7, 2023 /PRNewswire/ -- BIRKENSTOCK has appointed Tiffany Wu as Managing Director Greater China, effective November 1, 2023.
  • In this newly created position, Wu will lead the Greater China business area, which includes mainland China, Hong Kong and Taiwan, driving brand equity and sales in the region.
  • Oliver Reichert, Director of Birkenstock Holding plc and Chief Executive Officer of the BIRKENSTOCK Group: "Greater China is the strongest growth driver for us in the APMA region alongside India and Japan.
  • And in view of the latest economic outlook, we expect this positive trend to continue or accelerate.

Nuevocor presents pre-clinical data at ESGCT and AHA meetings

Retrieved on: 
Tuesday, November 7, 2023
AAV, Pathology, Zone, Congress, American Heart Association, Model, LMNA, AM, Poster, European Society of Gene and Cell Therapy, LINC, Cell, Disease, Gene, ESGCT, AHA, Pennsylvania Convention Center, Pharmaceutical industry, Science

SINGAPORE, Nov. 7, 2023 /PRNewswire/ -- Nuevocor, a pre-clinical stage biotechnology company focused on developing cardiac genetic medicines through a unique platform to understand the mechanobiological causes of disease, announced today a pair of presentations at two major meetings, the European Society for Gene and Cell Therapy (ESGCT) 30th Annual Congress, and the American Heart Association (AHA) Scientific Sessions 2023.

Key Points: 
  • SINGAPORE, Nov. 7, 2023 /PRNewswire/ -- Nuevocor, a pre-clinical stage biotechnology company focused on developing cardiac genetic medicines through a unique platform to understand the mechanobiological causes of disease, announced today a pair of presentations at two major meetings, the European Society for Gene and Cell Therapy (ESGCT) 30th Annual Congress, and the American Heart Association (AHA) Scientific Sessions 2023.
  • The poster presentations showcase optimization efforts for Nuevocor's first-in-class lead programme using a mechanobiology-based approach to treat LMNA-associated dilated cardiomyopathy.
  • At the ESGCT Congress on 24 – 27 October, 2023 in Brussels, Belgium, Nuevocor co-founder and Chief Executive Officer, Dr. Yann Chong Tan, presented a poster (P613) entitled "An AAV gene therapy for LMNA dilated cardiomyopathy via disruption of the LINC complex."
  • For more information on the meetings, please visit the respective conference websites.

Apnimed to Participate in Upcoming November Investor Conferences

Retrieved on: 
Monday, November 6, 2023
OSA, Conference, Obstructive sleep apnea, AM, Pharmaceutical industry

Apnimed will present from 1:50-2:20 PM ET and management will participate in 1x1 meetings.

Key Points: 
  • Apnimed will present from 1:50-2:20 PM ET and management will participate in 1x1 meetings.
  • 6th Annual Evercore ISI HealthCONx Conference: November 29, 2023, taking place in Miami, FL.
  • Apnimed will participate in a fireside chat from 8:45-9:15 AM ET and management will participate in 1x1 meetings.
  • Investors should contact their local sales representative for more details about conference registration and scheduling 1x1 meetings.

Galectin Therapeutics to Share Five Scientific Presentations at The Liver Meeting™ 2023, Hosted by the AASLD

Retrieved on: 
Friday, November 3, 2023
Hepatocyte, Hynes Convention Center, American Association for the Study of Liver Diseases, Therapy, Hepatology, Liver, Pharmacokinetics, Sarcopenia, Safety, GALT, Glomerular filtration rate, GA 2, AM, Abstract (summary), Obesity, Indiana University School of Medicine, Cirrhosis, Data monitoring committee, Disease, Hepatic hydrothorax, Medical school, Indiana University, SC 4, K–Ca dating, Non-alcoholic fatty liver disease, AASLD, Dietary supplement, Pharmaceutical industry, Flour, Patient

NORCROSS, Ga., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3, today announced that it will share five scientific presentations at The Liver Meeting™ 2023, hosted by the American Association for the Study of Liver Diseases (AASLD).

Key Points: 
  • NORCROSS, Ga., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3, today announced that it will share five scientific presentations at The Liver Meeting™ 2023, hosted by the American Association for the Study of Liver Diseases (AASLD).
  • The Liver Meeting™ will be held November 10-14, 2023, in Boston, Mass.
  • “This year again we are happy to share some of the progress we have made in our global program with belapectin, our galectin-3 inhibitor.
  • We are also proud to bring additional knowledge to the field regarding liver cirrhosis, a disease that dramatically affects the lives of our patients and has been neglected for far too long,” said Pol Boudes, M.D., Chief Medical Officer of Galectin Therapeutics.

ADC Therapeutics Announces Abstracts Accepted for Presentation at the 65th ASH Annual Meeting

Retrieved on: 
Thursday, November 2, 2023
Poster, NYSE, 65th Berlin International Film Festival, Doctor of Philosophy, Research, AM, Society, ASH, San Diego Convention Center, Diffuse large B-cell lymphoma, ADC, Abstract, Rituximab, Therapy, Manchester Grand Hyatt Hotel, Patient, Pharmaceutical industry, MD

LAUSANNE, Switzerland, Nov. 02, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced abstracts on ZYNLONTA® (loncastuximab tesirine-lpyl) have been accepted for presentation at the 65th American Society of Hematology (ASH) Annual Meeting, which will be held in San Diego, California from December 9-12, 2023.

Key Points: 
  • LAUSANNE, Switzerland, Nov. 02, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced abstracts on ZYNLONTA® (loncastuximab tesirine-lpyl) have been accepted for presentation at the 65th American Society of Hematology (ASH) Annual Meeting, which will be held in San Diego, California from December 9-12, 2023.
  • "We look forward to sharing insights from the growing body of research supporting the clinical utility of ZYNLONTA as a single agent and in combination with other treatments at the 65th ASH Annual Meeting,” said Mohamed Zaki, MD, PhD, Chief Medical Officer of ADC Therapeutics.
  • We look forward to additional details to be shared during the oral presentation.”
    Details of the oral presentation of the investigator-initiated study:
    Session: 623.
  • The abstracts are available through the ASH online meeting program.

Best’s Special Report: Best’s Impairment Rate and Rating Transition Study — 1977 to 2022

Retrieved on: 
Friday, November 3, 2023
Other Professional Services, Professional Services, Insurance, Delta, ICR, AM Best, News, FIC, AM, Rehabilitation, Cyclone, FSR, Risk, Zeta, Credit, Impairment rating, ALL, FICS

There were two insurers added to gross impairments in 2022, down from 10 carriers identified in the previous year.

Key Points: 
  • There were two insurers added to gross impairments in 2022, down from 10 carriers identified in the previous year.
  • The Best’s Special Report, titled, “Best’s Impairment Rate and Rating Transition Study — 1977 to 2022,” marks AM Best’s 20th study and is aimed at estimating the risk of impairment of U.S. insurers.
  • The analysis covers 45 one-year periods from Dec. 31, 1977, to Dec. 31, 2022, and includes U.S. insurers that had at least one Best’s Financial Strength Rating (FSR) or one corresponding Long-Term Issuer Credit Rating (ICR) during the study period.
  • None were rated by AM Best at the time of impairment, with 11 companies never rated by AM Best.

Best's Review Discusses the AI Revolution

Retrieved on: 
Friday, November 3, 2023
Professional Services, Technology, Other Professional Services, Other Technology, Insurance, Artificial Intelligence, Online, SOA, Virtual reality, AM Best, Regulator, Legislation, The State Insurance Organization of Turkmenistan, News, State, AM, Interview, Artificial intelligence, NXT TakeOver, Risk management, AI, ALL, Sunlight

The November issue of Best’s Review features a joint effort with AM Best TV to explore how artificial intelligence (AI) is impacting the insurance industry:

Key Points: 
  • The November issue of Best’s Review features a joint effort with AM Best TV to explore how artificial intelligence (AI) is impacting the insurance industry:
    “ How AI Is Remaking Insurance Organizations ” looks at where AI will have the most significant impact on how insurers conduct business, as well as some of the best practices for integrating the technology.
  • “ How AI Is Remaking the Insurance Workforce ” examines how AI will empower the insurance workforce by transforming roles and opening new avenues for value creation and claims management.
  • “ What the AI Revolution Means for Insurance Prospects, Policyholders and Regulators ” looks at the ways in which AI is likely to change how insurers identify risk opportunities and develop products, and how it will challenge regulators.
  • Best’s Review is AM Best’s monthly insurance magazine, covering emerging issues and trends and evaluating their impact on the marketplace.

AM Best Assigns Credit Ratings to Hadron Specialty Insurance Company

Retrieved on: 
Friday, November 3, 2023
Insurance, Professional Services, AM Best, Credit, News, AM, Risk management, ERM, ALL, Hadron

AM Best has assigned a Financial Strength Rating of A- (Excellent) and a Long-Term Issuer Credit Rating of “a-” (Excellent) to Hadron Specialty Insurance Company (Hadron) (Little Rock, AR).

Key Points: 
  • AM Best has assigned a Financial Strength Rating of A- (Excellent) and a Long-Term Issuer Credit Rating of “a-” (Excellent) to Hadron Specialty Insurance Company (Hadron) (Little Rock, AR).
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings .
  • For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments .
  • AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry.